A detailed history of Weaver Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Weaver Capital Management LLC holds 1,762 shares of LLY stock, worth $1.33 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
1,762
Previous 1,780 1.01%
Holding current value
$1.33 Million
Previous $1.61 Billion 3.14%
% of portfolio
0.47%
Previous 0.52%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$772.14 - $960.02 $13,898 - $17,280
-18 Reduced 1.01%
1,762 $1.56 Billion
Q2 2024

Aug 02, 2024

BUY
$724.87 - $909.04 $342,138 - $429,066
472 Added 36.09%
1,780 $1.61 Billion
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $5,922 - $7,922
-10 Reduced 0.76%
1,308 $1.02 Billion
Q4 2023

May 15, 2024

BUY
$525.19 - $619.13 $692,200 - $816,013
1,318 New
1,318 $768 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Weaver Capital Management LLC Portfolio

Follow Weaver Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weaver Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weaver Capital Management LLC with notifications on news.